Weigao

completed

The project consists of an investment program to be implemented by Shandong Weigao Group Medical Polymer Company Ltd. (Weigao or the company) over the next 3 years. The project will expand the existing production capacity of Weigao and its operating subsidiaries across several business lines and has the following components: - the expansion of Weigao’s production capacity for its existing product range (i.e., consumables that include syringes, sterile infusion sets, blood bags, intravenous needles);- the introduction of new blood purification products, kidney dialysis products, and the establishment of a chain of kidney dialysis treatment centers;- the expansion of orthopedic products production capacity; and - the expansion of drug-eluting stents production capacity. Weigao is the leading manufacturer of single-use medical supplies in China. Since establishment in 2000, its main operation has been the manufacturing of consumable products. The company’s strategic objective for growth is to expand into more technologically advanced, branded medical products of world-class quality, while continuing to be the domestic leader in manufacturing generic disposable medical products.